Steven J Hasal

3PUBLICATIONS
4CO-AUTHORS
HaematologyCancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Jul 14, 2025
A Phase 2 Clinical Trial of Oxylanthanum Carbonate in Patients Receiving Maintenance Hemodialysis with Hyperphosphatemia.

Geoffrey A Block, Glenn M Chertow, Guru Reddy

|Jul 21, 2020
A comparison of eflapegrastim to pegfilgrastim in the management of chemotherapy-induced neutropenia in patients with early-stage breast cancer undergoing cytotoxic chemotherapy (RECOVER): A Phase 3 study.

Patrick Wayne Cobb, Yong Wha Moon, Klára Mezei

|Jun 02, 2020
Eflapegrastim, a Long-Acting Granulocyte-Colony Stimulating Factor for the Management of Chemotherapy-Induced Neutropenia: Results of a Phase III Trial.

Lee S Schwartzberg, Gajanan Bhat, Julio Peguero

Pageof 1

Frequent Collaborators

1 joint publications

Lee S Schwartzberg

1 joint publications

Geoffrey A Block

1 joint publications

Glenn M Chertow

1 joint publications

Pablo E Pergola